MUTYH and KLF6 Gene Expression Fluctuations in Tumor Tissue and Tumor Margins Tissues of Colorectal Cancer

Overview

Journal J Egypt Natl Canc Inst

Specialty Oncology

Date 2022 Dec 4

PMID 36464752

Authors

Hoora Naebi

Ahmadreza Bandegi

Fereshteh Talebinasab

Pirouz Samidoust

Seyedeh Elham Norollahi

Sogand Vahidi

Ali Akbar Samadani

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer (CRC) is one of the most important cancers in the world, and its prevalence varies depending on the geographical area. Genetically, tumor regeneration in CRC as a multi-step process involves activating mutations in protocogenes and losing the function of tumor suppressor genes as well as DNA repair and recovery genes. Occur in this way, our goal was to investigate the expression of KLF6 genes as a tumor suppressor and MUTYH involved in the DNA repair process in colorectal cancer.

Methods: This research was conducted during the years 2019-2018 in Razi Hospital, Rasht. The subjects included 30 tumoral and 30 non-tumoral tissues of colorectal cancer and 20 healthy controls. The real-time PCR method was used to investigate the gene expression. For data analysis by SPSS, parametric statistical tests ANOVA and T test and regression analysis were used and p value values less than 0.05 were considered significant.

Results: The expression of KLF6 gene in tumoral tissues showed a significant decrease compared to non-tumoral tissues (P = 0.04). Also, the expression of MUTYH gene in tumor tissue showed a significant decrease compared to non-tumoral (P = 0.02) and this decrease in MUTYH gene expression had a significant relationship with increasing tumor stage (P = 0.01).

Conclusion: These findings suggest that decreased expression of KLF6 and MUTYH genes in the study population has a significant relationship with colorectal cancer and can be considered as tumor marker in diagnostic purpose.

References

Vaiopoulos A, Athanasoula K, Papavassiliou A . Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges. Biochim Biophys Acta. 2014; 1842(7):971-80. DOI: 10.1016/j.bbadis.2014.02.006. View

Okugawa Y, Grady W, Goel A . Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology. 2015; 149(5):1204-1225.e12. PMC: 4589488. DOI: 10.1053/j.gastro.2015.07.011. View

Choong M, Tsafnat G . Genetic and epigenetic biomarkers of colorectal cancer. Clin Gastroenterol Hepatol. 2011; 10(1):9-15. DOI: 10.1016/j.cgh.2011.04.020. View

Gismondi V, Meta M, Bonelli L, Radice P, Sala P, Bertario L . Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer. 2004; 109(5):680-4. DOI: 10.1002/ijc.20054. View

Banda D, Nunez N, Burnside M, Bradshaw K, David S . Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine. Free Radic Biol Med. 2017; 107:202-215. PMC: 5457711. DOI: 10.1016/j.freeradbiomed.2017.01.008. View

Viel A, Bruselles A, Meccia E, Fornasarig M, Quaia M, Canzonieri V . A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer. EBioMedicine. 2017; 20:39-49. PMC: 5478212. DOI: 10.1016/j.ebiom.2017.04.022. View

Reeves H, Narla G, Ogunbiyi O, Haq A, Katz A, Benzeno S . Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology. 2004; 126(4):1090-103. DOI: 10.1053/j.gastro.2004.01.005. View

Koivisto P, Zhang X, Sallinen S, Sallinen P, Helin H, Dong J . Absence of KLF6 gene mutations in human astrocytic tumors and cell lines. Int J Cancer. 2004; 111(4):642-3. DOI: 10.1002/ijc.20301. View

Chen H, Liu X, Lin J, Chen T, Feng Q, Zeng Y . [Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas]. Ai Zheng. 2003; 21(10):1047-50. View

10.

Chen C, Hyytinen E, Sun X, Helin H, Koivisto P, Frierson Jr H . Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol. 2003; 162(4):1349-54. PMC: 1851229. DOI: 10.1016/S0002-9440(10)63930-2. View

11.

Cho Y, Choi B, Song J, Kim S, Nam S, Lee S . Aberrant expression of krUppel-like factor 6 protein in colorectal cancers. World J Gastroenterol. 2006; 12(14):2250-3. PMC: 4087656. DOI: 10.3748/wjg.v12.i14.2250. View

12.

Lievre A, Landi B, Cote J, Veyrie N, Zucman-Rossi J, Berger A . Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers. Oncogene. 2005; 24(48):7253-6. DOI: 10.1038/sj.onc.1208867. View

13.

Zhang S, Zhang J, Lu L, Wang C, Wang L . MiR-630 promotes epithelial ovarian cancer proliferation and invasion via targeting KLF6. Eur Rev Med Pharmacol Sci. 2017; 21(20):4542-4547. View

14.

Kuno T, Matsubara N, Tsuda S, Kobayashi M, Hamanaka M, Yamagishi D . Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer. Oncol Rep. 2012; 28(2):473-80. DOI: 10.3892/or.2012.1836. View

15.

Takao M, Yamaguchi T, Eguchi H, Tada Y, Kohda M, Koizumi K . Characteristics of MUTYH variants in Japanese colorectal polyposis patients. Int J Clin Oncol. 2018; 23(3):497-503. DOI: 10.1007/s10147-017-1234-7. View

16.

Nascimento E, Ribeiro M, Magro D, Carvalho J, Kanno D, Martinez C . TISSUE EXPRESION OF THE GENES MUTYH AND OGG1 IN PATIENTS WITH SPORADIC COLORECTAL CANCER. Arq Bras Cir Dig. 2017; 30(2):98-102. PMC: 5543786. DOI: 10.1590/0102-6720201700020005. View

17.

Dumanski J, Rasi C, Bjorklund P, Davies H, Ali A, Gronberg M . A germline mutation is associated with small intestinal neuroendocrine tumors. Endocr Relat Cancer. 2017; 24(8):427-443. PMC: 5527373. DOI: 10.1530/ERC-17-0196. View